Abstract:The oral and lung microbiomes connection through the oral–lung axis leads to an oral and lung health and disease intimate and bi‐directional relationship. In this mini‐review, we discuss opportunities for the airway microbiome to make a positive impact on the clinical management of respiratory health, aimed at personalization and assisted by multi‐omics data integration and computational modelling. The human respiratory system is constantly exposed to environmental stimuli, sometimes including toxicants, which can trigger dysregulated lung immune responses that lead to respiratory symptoms, impaired lung function and airway diseases. Evidence supports that the microbiome in the lungs has an indispensable role in respiratory health and disease, acting as a local gatekeeper that mediates the interaction between the environmental cues and respiratory health. Moreover, the microbiome in the lungs is intimately intertwined with the oral microbiome through the oral–lung axis. Here, we discuss the intricate three‐way relationship between (i) cigarette smoking, which has strong effects on the microbial community structure of the lung; (ii) microbiome dysbiosis and disease in the oral cavity; and (iii) microbiome dysbiosis in the lung and its causal role in patients suffering chronic obstructive pulmonary disease (COPD), a leading cause of morbidity and mortality worldwide. We highlight exciting outcomes arising from recently established interactions in the airway between environmental exposures, microbiome, metabolites–functional attributes and the host, as well as how these associations have the potential to predict the respiratory health status of the host through an airway microbiome health index. For completion, we argue that incorporating (synthetic) microbial community ecology in our contemporary understanding of lung disease presents challenges and also rises novel opportunities to exploit the oral–lung axis and its microbiome towards innovative airway disease diagnostics, prognostics, patient stratification and microbiota‐targeted clinical interventions in the context of current therapies.

Human matters in asthma: Considering the microbiome in pulmonary health

Influence and effect of the human microbiome in allergy and asthma

Environmental influences on childhood asthma—The effect of diet and microbiome on asthma

Gut microbiota dysbiosis and its impact on asthma and other lung diseases: potential therapeutic approaches

Asthma and the microbiome: defining the critical window in early life

The Human Respiratory Microbiome: Current Understandings and Future Directions

Microbiome and Asthma: Microbial Dysbiosis and the Origins, Phenotypes, Persistence, and Severity of Asthma

Microbiome diversity, intra-mucosal bacteria and immune integration within normal and asthmatic airway mucosa

Environmental exposures, the oral–lung axis and respiratory health: The airway microbiome goes on stage for the personalized management of human lung function

Cross-domain microbiomes: the interaction of gut, lung and environmental microbiota in asthma pathogenesis

Nasal Microbiome and Its Interaction with the Host in Childhood Asthma

Can Therapeutic Targeting of the Human Microbiome Influence Asthma Management? A Pro/Con Debate

Influence of the gut and airway microbiome on asthma development and disease

Microbial dysbiosis and childhood asthma development: Integrated role of the airway and gut microbiome, environmental exposures, and host metabolic and immune response

Microbes little helpers and suppliers for therapeutic asthma approaches

The Role of Gut Bacteriome in Asthma, Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnoea

The Lower Airway Microbiome in Paediatric Health and Chronic Disease

The Role of the Microbiome in Allergy, Asthma, and Occupational Lung Disease

Gut microecological regulation on bronchiolitis and asthma in children: A review

The Microbiota in Children and Adolescents with Asthma

Possible role of gut microbes and host’s immune response in gut–lung homeostasis